The platform describes its program as combining GLP-1 medications, licensed medical care, and ongoing support delivered entirely online, without office visits, insurance requirements, or separate pharmacy lines
Next-Generation Poly-agonists The success of tirzepatide demonstrated the superior efficacy of targeting multiple hormonal pathways
[3] In another research study it was hypothesized that BPC-157 may have led to an acceleration in wound closure compared to the control group via an improvement in the formation of granulation tissue, reepithelialization, dermal remodeling, and collagen deposition
Protective factors such as Nrf2 and SLC7A11/GPX4 can counteract this process by reducing oxidative damage (Wan et al., 2023)
But what sets these two apart, and which one is better for your goals